Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 4 | 0 | 11 | 2,911 | 0 |
| Gross Profit | 4 | N/A | 11 | 2,911 | N/A |
| Operating Expenses | 7,986 | 9,672 | 8,534 | 11,175 | 9,233 |
| Operating Income | -7,982 | -9,672 | -8,523 | -8,264 | -9,233 |
| Interest Expense | 1,068 | 853 | 890 | 841 | 740 |
| Other Income | 277 | 477 | 254 | 254 | 41 |
| Pre-tax Income | -8,773 | -10,048 | -9,159 | -8,851 | -9,932 |
| Net Income Continuous | -8,773 | -10,048 | -9,159 | -8,851 | -9,932 |
| Net Income | $-8,773 | $-10,048 | $-9,159 | $-8,851 | $-9,932 |
| EPS Basic Total Ops | -5.49 | -6.30 | -5.11 | -6.00 | -7.50 |
| EPS Basic Continuous Ops | -5.49 | -6.29 | -6.14 | -6.17 | -6.93 |
| EPS Diluted Total Ops | -5.49 | -6.30 | -5.11 | -6.00 | -7.50 |
| EPS Diluted Continuous Ops | -5.49 | -6.29 | -6.14 | -6.17 | -6.93 |
| EBITDA(a) | $-6,416 | $-8,504 | $-7,482 | $-7,344 | $-8,341 |